Terms: = Lymphoma AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Diagnosis
43 results:
1. Indolent T-Cell/Natural Killer-Cell lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
Wang XG; Yin WH; Wang HY
Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
[TBL] [Abstract] [Full Text] [Related]
2. The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line.
Rahmani R; Eivazi N; Emamgholipour S; Aminian M; Jalilian A; Paknejad M
Mol Biol Rep; 2024 Feb; 51(1):250. PubMed ID: 38302816
[TBL] [Abstract] [Full Text] [Related]
3. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice.
Yu J; Zhao B; Pi Q; Zhou G; Cheng Z; Qu C; Wang X; Kong L; Luo S; Du D; Guo Y
Respir Res; 2023 Nov; 24(1):288. PubMed ID: 37978525
[TBL] [Abstract] [Full Text] [Related]
4. Phosphorylated stat3 as a potential diagnostic and predictive biomarker in ALK
Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
[TBL] [Abstract] [Full Text] [Related]
5. [A particular presentation of a T cell large granular lymphocytic leukaemia].
Donzel M; Bon Mardion M; Balme B
Ann Pathol; 2023 Jan; 43(1):52-56. PubMed ID: 36494259
[TBL] [Abstract] [Full Text] [Related]
6. Hyper-IgE and Carcinoma in CADINS Disease.
Pietzsch L; Körholz J; Boschann F; Sergon M; Dorjbal B; Yee D; Gilly V; Kämmerer E; Paul D; Kastl C; Laass MW; Berner R; Jacobsen EM; Roesler J; Aust D; Lee-Kirsch MA; Snow AL; Schuetz C
Front Immunol; 2022; 13():878989. PubMed ID: 35651609
[TBL] [Abstract] [Full Text] [Related]
7. CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1.
Dong L; Huang J; Gao X; Du J; Wang Y; Zhao L
Cancer Sci; 2022 Aug; 113(8):2888-2903. PubMed ID: 35579082
[TBL] [Abstract] [Full Text] [Related]
8. Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes.
Masciopinto P; Bellitti E; Arcuti E; Battisti O; Cazzato G; Perrone T; Longo MC; Laddaga FE; Maiorano E; Musto P; Ingravallo G; Gaudio F
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e745-e750. PubMed ID: 35501257
[TBL] [Abstract] [Full Text] [Related]
9. Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma.
Hiwatari M; Seki M; Matsuno R; Yoshida K; Nagasawa T; Sato-Otsubo A; Yamamoto S; Kato M; Watanabe K; Sekiguchi M; Miyano S; Ogawa S; Takita J
Oncogene; 2022 May; 41(20):2789-2797. PubMed ID: 35411036
[TBL] [Abstract] [Full Text] [Related]
10. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
Bisig B; Cairoli A; Gaide O; Somja J; Bregnard C; Gaulard P; Xerri L; Lefort K; Missiaglia E; Gilliet M; Hohl D; Guenova E; de Leval L
Virchows Arch; 2022 Oct; 481(4):653-657. PubMed ID: 35366115
[TBL] [Abstract] [Full Text] [Related]
11. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early diagnosis and Management.
López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
Front Immunol; 2021; 12():671755. PubMed ID: 34447369
[TBL] [Abstract] [Full Text] [Related]
12. EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (stat3) pathway mutations and unique clinicopathologic features.
Chapman JR; Bouska AC; Zhang W; Alderuccio JP; Lossos IS; Rimsza LM; Maguire A; Yi S; Chan WC; Vega F; Song JY
Br J Haematol; 2021 Sep; 194(5):870-878. PubMed ID: 34272731
[TBL] [Abstract] [Full Text] [Related]
13. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
Ramis-Zaldivar JE; Gonzalez-Farre B; Nicolae A; Pack S; Clot G; Nadeu F; Mottok A; Horn H; Song JY; Fu K; Wright G; Gascoyne RD; Chan WC; Scott DW; Feldman AL; Valera A; Enjuanes A; Braziel RM; Smeland EB; Staudt LM; Rosenwald A; Rimsza LM; Ott G; Jaffe ES; Salaverria I; Campo E
Haematologica; 2021 Oct; 106(10):2682-2693. PubMed ID: 33951889
[TBL] [Abstract] [Full Text] [Related]
14. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
Kadin ME; Xu H; Hunsicker LM; Guan Y
Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
[TBL] [Abstract] [Full Text] [Related]
15. TYK2 Variants in B-Acute Lymphoblastic Leukaemia.
Turrubiartes-Martínez E; Bodega-Mayor I; Delgado-Wicke P; Molina-Jiménez F; Casique-Aguirre D; González-Andrade M; Rapado I; Camós M; Díaz-de-Heredia C; Barragán E; Ramírez-Orellana M; Aguado B; Figuera Á; Martínez-López J; Fernández-Ruiz E
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260630
[TBL] [Abstract] [Full Text] [Related]
16. Silencing stat3 inhibits viability and induces apoptosis in BGC-823 human gastric cancer cell line.
Xu Y; Feng S; Niu B
Biotech Histochem; 2021 Jan; 96(1):76-81. PubMed ID: 32619110
[TBL] [Abstract] [Full Text] [Related]
17. Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL.
Guerrero CLH; Yamashita Y; Miyara M; Imaizumi N; Kato M; Sakihama S; Hayashi M; Miyagi T; Karimata K; Uchihara J; Ohshiro K; Todoroki J; Nakachi S; Morishima S; Karube K; Tanaka Y; Masuzaki H; Fukushima T
Blood Adv; 2020 Mar; 4(6):1062-1071. PubMed ID: 32196559
[TBL] [Abstract] [Full Text] [Related]
18. Refractory Celiac Disease.
Hujoel IA; Murray JA
Curr Gastroenterol Rep; 2020 Mar; 22(4):18. PubMed ID: 32185560
[TBL] [Abstract] [Full Text] [Related]
19. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
[TBL] [Abstract] [Full Text] [Related]
20. Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway.
Liu K; Wu Z; Chu J; Yang L; Wang N
Biomed Pharmacother; 2019 Jul; 115():108913. PubMed ID: 31054507
[TBL] [Abstract] [Full Text] [Related]
[Next]
